ArticleDigital biomarkers
Methods for Wearable-Derived Pulse Rate Measures and Their Application to Modeling the Relationship between Pulse Rate and Motor Activity in Narcolepsy Type 1.
Article in Digital biomarkers. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05687903 (A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-861 for the Treatment of Narcolepsy With Cataplexy), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-861 for the Treatment of Narcolepsy With Cataplexy (Narcolepsy Type 1)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Narcolepsy type 1 (NT1) is a chronic, rare neurological disorder caused by loss of orexin neurons that disrupts the sleep-wake cycle. Current research suggests a link between orexin neuropeptide deficiency and heart rate regulation. Wrist-worn devices enable continuous monitoring of physiological data, including heart rate. We aim to effectively utilize wearables in clinical research by developing robust methodologies to address challenges including data artifacts and missing data. Methods: Empatica wrist-worn smartwatch data were collected for 2 weeks at baseline in the TAK-861-2001 randomized, phase 2 clinical trial (NCT05687903) from participants with NT1. Epoch-level (minute-level) pulse rate data were rigorously screened for artifacts. Daily pulse rate measures (24-h, daytime, and nighttime averages) were derived. Numerical experiments were conducted to evaluate the stability of daily measures as a function of the proportion of valid minute-level data within a given day. Mean pulse rate and motor activity daily measures and the association between the two were quantified using linear mixed-effects models. Results: Participants ( Conclusion: This work proposes a robust framework for preprocessing smartwatch pulse rate data for analyses in clinical research. The findings from our smartwatch data demonstrate a significant positive association between pulse rate and motor activity in participants with NT1 during a 2-week baseline period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.